Construction of the plant will commence in 2025 with first production expected to be in 2027
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
Subscribe To Our Newsletter & Stay Updated
